Clinical Trial Update: A Study of PAD Versus Velcade, Cyclophosphamide and Dexamethasone (VCD) Treatment in Subjects With Multiple Myeloma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing PAD versus Velcade, Cyclophosphamide and Dexamethasone (VCD) in multiple myeloma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Velcade (bortezomib)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Multiple Myeloma | Phase 4 | Status: UNKNOWN